Bloom Burton & Co.
Jolyon Burton is a co-founder of Bloom Burton & Co. and serves as the firm’s President and Head of Investment Banking.
As trusted advisors to boards of directors, management teams, and professional and strategic investors, Jolyon and his team help structure and execute financial and capital markets strategies, mergers and acquisitions or other partnering transactions. The team has been directly involved in financings of over $3 billion as well as mergers and acquisitions transactions valued at more than $2 billion.
In the role immediately preceding the co-founding of Bloom Burton, Jolyon served as the Head of Healthcare & Biotechnology Investment Banking at an independent investment dealer. Jolyon started his career in roles that helped internationally focused growth companies, both at Export Development Canada and at Global Affairs Canada.
Jolyon serves on the Board of Directors of NeuPath Health (TSXV:NPTH) and on the Board of Directors of Grey Wolf Animal Health. He is a graduate of the University of Waterloo with an Honours Bachelor of Arts in Applied Studies, with a Major in Economics and Specializations in Finance and International Trade and received the Department of Economics award for academic achievement among his graduating class.
Bloom Burton & Co.
Bloom Burton & Co. is a firm dedicated to accelerating returns in the healthcare sector for both investors and companies. Bloom Burton is comprised of medical, scientific, pharmaceutical, financial, legal and capital markets professionals with significant depth of experience. Their broad expertise enables them to take a creative, innovative, and entrepreneurial approach when assisting their clients with the achievement of the right monetization events.